Systematic review and meta-analysis:: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure

被引:256
作者
Gisbert, JP [1 ]
De La Morena, F [1 ]
机构
[1] Univ Hosp La Princesa, Dept Gastroenterol, Madrid, Spain
关键词
D O I
10.1111/j.1365-2036.2006.02737.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background A quadruple therapy has been generally recommended as rescue regimen for Helicobacter pylori eradication failures. Aims To systematically review the efficacy and tolerance of levofloxacin-based rescue regimens, and to conduct a meta-analysis of studies comparing these regimens with quadruple therapy for H. pylori eradication failures. Methods Selection of studies levofloxacin-based rescue regimens. For the meta-analysis, randomized-controlled trials comparing levofloxacin-based and quadruple regimens. Search strategy - electronic and manual. Assessment of study quality - independently by two reviewers. Data synthesis - 'intention -to-treat' eradication rate. Results Mean eradication rate with levofloxacin-based regimens was 80%. Tenday regimens were more effective than 7-day combinations (810/6 vs. 73%; P < 0.0 1). The meta-analysis showed better results with levofloxacin than with the quadruple combination (81% vs. 70%; OR = 1.80; 95% CI = 0.94-3.46). This difference reached statistical significance and heterogeneity markedly decreased when a single outlier study was excluded or when only high-quality studies were considered. Meta-analysis showed less adverse effects with levofloxacin than with quadruple regimen, both overall (19% vs. 44%; OR = 0.27; 95% Cl = 0.16-0.46) and regarding severe adverse effects (0.80/6 vs. 8.4%; OR = 0.20; 95% Cl =0.06-0.67). Conclusions After H. pylori eradication failure, levofloxacin-based rescue regimen is more effective and better tolerated than the generally recommended quadruple therapy. A 10-day combination of levofloxacin-amoxicillin-proton pump inhibitor constitutes an encouraging second-line alternative.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 41 条
[1]   A 10-Day Levofloxacin-Based Therapy in Patients With Resistant Helicobacter pylori Infection: A Controlled Trial [J].
Bilardi, Claudio ;
Dulbecco, Pietro ;
Zentilin, Patrizia ;
Reglioni, Simona ;
Iiritano, Elena ;
Parodi, Andrea ;
Accornero, Laura ;
Savarino, Edoardo ;
Mansi, Carlo ;
Mamone, Mario ;
Vigneri, Sergio ;
Savarino, Vincenzo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (11) :997-1002
[2]   Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999) [J].
Cabrita, J ;
Oleastro, M ;
Matos, R ;
Manhente, A ;
Cabral, J ;
Barros, R ;
Lopes, AI ;
Ramalho, P ;
Neves, BC ;
Guerreiro, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1029-1031
[3]   High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection [J].
Cammarota, G ;
Martino, A ;
Pirozzi, G ;
Cianci, R ;
Branca, G ;
Nista, EC ;
Cazzato, A ;
Cannizzaro, O ;
Miele, L ;
Grieco, A ;
Gasbarrini, A ;
Gasbarrini, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (07) :789-795
[4]   New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures:: a pilot study [J].
Coelho, LGV ;
Moretzsohn, LD ;
Vieira, WLS ;
Gallo, MA ;
Passos, MCF ;
Cindr, JM ;
Cerqueira, MC ;
Vitiello, L ;
Ribeiro, ML ;
Mendonça, S ;
Pedrazzoli, J ;
Castro, LP .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) :783-787
[5]   Levofloxacin - A review of its use in the treatment of bacterial infections in the United States [J].
Croom, KF ;
Goa, KL .
DRUGS, 2003, 63 (24) :2769-2802
[6]  
Díez JMB, 2000, MED CLIN-BARCELONA, V115, P617
[7]  
Elizalde IR, 1998, ANAL SIS SAN NAVA S2, V21, P83
[8]  
Gasbarrini A, 2000, SCAND J GASTROENTERO, V35, P260, DOI 10.1080/003655200750024119
[9]   A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses [J].
Gatta, L ;
Zullo, A ;
Perna, F ;
Ricci, C ;
De Francesco, V ;
Tampieri, A ;
Bernabucci, V ;
Cavina, M ;
Hassan, C ;
Ierardi, E ;
Morini, S ;
Vaira, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (01) :45-49
[10]  
Gisbert JP, 1999, ALIMENT PHARM THERAP, V13, P1311